Cholesteryl ester flux from HDL to VLDL-1 is preferentially enhanced in type IIB hyperlipidemia in the postprandial state

Journal of Lipid Research

Volumn 43, Issue 10, 2002, Pages 1652-1660

  Guerin, Maryse ^a   Egger, Pascal ^a   Soudant, Céline ^a   Goff, Wilfried Le ^a   Van Tol, Arie ^b   Dupuis, Reynald ^c   John Chapman, M ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c PFIZER INC   (United States)

Author keywords

Atherosclerosis; Cellular cholesterol efflux; Cholesteryl ester transfer protein; Lecithin:cholesterol acyltransferase

Indexed keywords

CHOLESTEROL ESTER; HIGH DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD SAMPLING; CHOLESTEROL TRANSPORT; CLINICAL ARTICLE; ENZYME ACTIVITY; ESTERIFICATION; HUMAN; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; LIPOLYSIS; LIPOPROTEIN METABOLISM; MALE; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ADULT; AGED; ANALYSIS OF VARIANCE; CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL ESTERS; CHOLESTEROL, HDL; CHOLESTEROL, VLDL; GLYCOPROTEINS; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; KINETICS; LIPOPROTEINS; MALE; MIDDLE AGED; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; POSTPRANDIAL PERIOD; TRIGLYCERIDES;

EID: 0036795589     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M200135-JLR200     Document Type: Article

References (40)

1. Tall, A. 1995. Plasma lipid transfer proteins. Annu. Rev. Biochem. 64: 235-257.
2. Goldberg, D. I., W. F. Beltz, and R. C. Pitiman. 1991. Evaluation of pathways for the cellular uptake of high density lipoprotein cholesterol esters in rabbits J Clin Invest. 87: 331-346.
3. Arad, Y., R. Ramakrishnan, and H. N. Ginsberg. 1990. Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reducing the production of apoB-containing lipoproteins: implications for the pathophysiology of apoB production. J Lipid Res. 31: 567-582.
4. Guerin, M., T. S. Lassel, W. Le Golf, M. Farnier, and M. J. Chapman. 2000. Action of atorvastatin in combined hyperlipidemia: preferential reduction of cholesteryl ester transfer from HDL to VLDL1 particles. Arterioscler. Thromb. Vasc. Biol. 20: 189-197.
5. Packard, C. J., and J. Shepherd. 1997. Lipoprotein heterogeneity, and apolipoprotein B metabolism. Arterioscler. Thromb. Vasc. Biol. 17: 3542-3556.
6. Guerin, M., W. Le Goff, T. S. Lassel, A. van Tol, G. Steiner, and M. J. Chapman. 2001. Proatherogenic role of elevated CE transfer from HDL to VLDL(1) and dense LDL in type 2 diabetes: impact of the degree of triglyceridemia. Arterioscler. Thromb. Vasc, Biol. 21: 282-288.
7. Karpe, F., and A. Hamsten. 1995. Postprandial lipoprotein metabolism and atherosclerosis. Curr. Opin. Lipidol. 6: 123-129.
8. Patsch, J. R., G. Miesenbock, T. Hopferwieser, V. Muhlberger, E. Knapp, J. K. Dunn, A. M., Gotto, Jr., and W. Patsch. 1992. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler. Thromb. 12: 1336-1345.
9. Zilversmit, D. B. 1995. Atherogenic nature of triglycerides, postprandial lipidemia, and triglyceride-rich remnant lipoproteins. Clin. Chem. 41: 153-158.
10. Tall, A., D. Sammett, and E. Granot. 1986. Mechanisms of enhanced cholesteryl ester transfer from high density lipoproteins to apolipoprotein B-containing lipoproteins during alimentary lipemia. J. Clin. Invest. 77: 1163-1172.
11. Castro, G. R., and C.J. Fielding. 1985. Effects of postprandial lipemia on plasma cholesterol metabolism. J. Clin. Invest. 75: 874-882.
12. Contacos, C., P.J. Barter, L. Vrga, and D. R. Sullivan. 1998. Cholesteryl ester transfer in hypercholesterolaemia: fasting and postprandial studies with and without pravastatin. Atherosclerosis. 141: 87-98.
13. Castro, G. R., and C.J. Fielding. 1988. Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein. Biochemistry. 27: 25-29.
14. Rose, H. G., and J. Juliano. 1977. Regulation of plasma lecithin:cholesterol acyltransferase. II. Activation during alimentary lipemia. J. Lab. Clin. Med. 89: 525-532.
15. Marcel, Y. L., and C. Vezina. 1973. Lecithin: cholesterol acyltransferase of human plasma. Role of chylomicrons, very low, and high density lipoproteins in the reaction. J. Biol. Chem. 248: 8254-8259.
16. Wallentin, L., and O. Vikrot. 1976. Influence of fat ingestion on lecithin:cholesterol acyl transfer rate in plasma from normal persons. Scand. J. Clin. Lab. Invest. 36: 473-479.
17. Mero, N., A. Van Tol, L. M. Scheek, T. Van Gent, C. Labeur, M. Rosseneu, and M. R. Taskinen. 1998. Decreased postprandial high density lipoprotein cholesterol and apolipoproteins A-I and E in normolipidemic smoking men: relations with lipid transfer proteins and LCAT activities. J. Lipid Res. 39: 1493-1502.
18. Chung, B. H., E Franklin, B. H. S. Cho, J. P. Segrest, K. Hart, and B. E. Darnell. 1998. Potencies of lipoproteins in fasting and postprandial plasma to accept additional cholesterol molecules released from cell membranes. Arterioscler. Thromb. Vasc. Biol. 18: 1217-1230.
19. Simpson, H. S., C. M. Williamson, T. Olivecrona, S. Pringle, J. Maclean, A. R. Lorimer, F. Bonnefous, Y. Bogaievsky, C. J. Packard, and J. Shepherd. 1990. Postprandial lipemia, fenofibrate and coronary artery disease. Atherosclerosis. 85: 193-202.
20. Ji, Y., B. Jian, N. Wang, Y. Sun, M. L. Moya, M. C. Phillips, G. H. Rothblat, J. B. Swaney, and A. R. Tall. 1997. Scavenger receptor B1 promotes high density lipoprotein-mediated cellular cholesterol efflux. J. Biol. Chem. 272: 20982-20985.
21. Owen, J. S. 1999. Role of ABC1 gene in cholesterol efflux and atheroprotection. Lancet. 354: 1402-1403.
22. Jiang, X. C., C. Bruce, J. Mar, M. Lin, Y. Ji, O. L. Francone, and A. R. Tall. 1999. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. J. Clin. Invest. 103: 907-914.
23. Tall, A. R., X. Jiang, Y. Luo, and D. Silver. 2000. George Lyman Duff memorial lecture: lipid transfer proteins, HDL metabolism, and atherogenesis. Arterioscler. Thromb. Vasc. Biol. 20: 1185-1188.
24. Acton, S., A. Rigotti, K. T. Landschulz, S. Xu, H. H. Hobbs, and M. Krieger. 1996. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science. 271: 518-520.
25. Mahley, R. W., and Z. S. Ji. 1999. Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. J. Lipid Res. 40: 1-16.
26. Lassel, T. S., M. Guerin, S. Auboiron, M. J. Chapman, and B. Guy-Grand. 1998. Preferential cholesteryl ester acceptors among TRL during alimentary lipemia in normolipidemic subjects. Arterioscler. Thromb. Vasc. Biol. 18, 65-74.
27. Chapman, M. J., S. Goldstein, D. Lagrange, and P. M. Laplaud. 1981. A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum. J. Lipid Res. 22: 339-358.
28. Durrington, P. N., M. I. Mackness, D. Bhatnagar, K. Julier, H. Prais, S. Arrol, J. Morgan, and G. N. Wood. 1998. Effects of two different fibric acid derivatives on lipoproteins, cholesteryl ester transfer, fibrinogen, plasminogen activator inhibitor and paraoxonase activity in type IIB hyperlipoproteinaemia. Atherosclerosis. 138: 217-225.
29. de la Llera Moya, M., V. Atger, J. L. Paul, N. Fournier, N. Moatti, P. Giral, K. E. Friday, and G. Rothblat. 1994. A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Relations between serum components and efflux, esterification, and transfer. Arterioscler Thromb. 14: 1056-1065.
30. Rothblat, G., M. de la Llera Moya, V. Atger, G. Kellner-Weibel, D. L. Williams, and M. C. Phillips. 1999, Cell cholesterol efflux: integration of old and new observations provides new insights. J. Lipid Res. 40: 781-796.
31. Albers, J. J., C. H. Chen, and A. G. Lacko. 1986. Isolation, characterization, and assay of lecithin-cholesterol acyltransferase. Methods Enzymol. 129: 763-783.
32. Guerin, M., P. J. Dolphin, and M. J. Chapman. 1994. A new in vitro method for the simultaneous evaluation of cholesteryl ester exchange and mass transfer between HDL and apoB-containing lipoprotein subspecies. Identification of preferential cholesteryl ester acceptors in human plasma. Arterioscler Thromb. 14: 199-206.
33. Chinetti, G., G. F. Gbaguidi, S. Griglio, Z. Mallat, M. Antonucci, P. Poulain, M. J. Chapman, J. C. Fruchart, A. Tedgui, J. Najib-Fruchart, and B. Staels. 2000. CLA-1/SRBI is expressed in atherosclerostic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors. Circulation. 101: 2411-2417.
34. Lefevre, M., C. H. Sloop, and P. S. Roheim. 1988. Characterization of dog prenodal peripheral lymph lipoproteins. Evidence for the peripheral formation of lipoprotein-unassociated apoA-I with slow pre-beta electrophoretic mobility. J Lipid Res. 29: 1139-1148.
35. Jian, B., M. de la Llera-Moya, L. Royer, G. Rothblat, O. Francone, and J. B. Swaney. 1997. Modification of the cholesterol efflux properties of human serum by enrichment with phospholipid. J. Lipid Res. 38: 734-744.
36. von Eckardstein, A., M. Jauhiainen, Y. Huang, J. Metso, C. Langer, P. Pussinen, S. Wu, C. Ehnholm, and G. Assmann. 1996. Phospholipid transfer protein mediated conversion of high density lipoproteins generates pre beta 1-HDL. Biochim. Biophys. Acta. 1301: 255-262.
37. Morton, R. E. 1988. Free cholesterol is a potent regulator of lipid transfer protein function. J. Biol. Chem. 263: 12235-12241.
38. Lagrost, L. and P. J. Barter, 1991. Effects of various non-esterified fatty acids on the transfer of cholesteryl esters from HDL to LDL induced by the cholesteryl ester transfer protein. Biochim. Biophys. Acta. 1085: 209-216.
39. Meijssen, S., M. C. Cabezas, T. B. Twickler, H. Jansen, and D. W. Erkelens. 2000. In vivo evidence of defective postprandial and post-absorptive free fatty acid metabolism in familial combined hyperlipidemia. J. Lipid Res. 41: 1096-1102.
40. Karpe, F., G. Steiner, T. Olivecrona, L. A. Carlson, and A. Hamsten. 1993. Metabolism of TRL during alimentary lipemia. J. Clin. Invest. 91: 748-758.